1. 128 SINGLE CENTER EXPERIENCE OF RIC BASED ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 100 PATIENTS WITH MDS. Issue 1 (April 2015) Authors: Blaise, D.; Saillard, C.; Fürst, S.; Faucher, C.; Prebet, T.; El Cheikh, J.; Castagna, L.; Charbonnier, A.; Granata, A.; Rey, J.; Devillier, R.; Mohty, B.; Arnoulet, C.; Moziconnaci, M.J.; Chabannon, C.; Vey, N. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 133 UNRELATED CORD BLOOD OR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS RECEIVING A REDUCED INTENSITY CONDITIONING REGIMEN: AN EBMT STUDY. Issue 1 (April 2015) Authors: Robin, M.; Ruggeri, A.; Labopin, M.; Nierderwieser, D.; Tabrizi, R.; Sanz, G.; Bouhris, J.H.; Van Biezen, A.; Koenecke, C.; Blaise, D.; Tischer, J.; Craddock, C.; Maillard, N.; Mohty, M.; Russel, N.; Schetelig, J.; Finke, J.; Gluckman, E.; De Witte, T.; Rocha, V. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 134 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LOWER RISK MDS PATIENTS : A RETROSPECTIVE STUDY ON BEHALF OF THE CMWP OF THE EBMT. (April 2015) Authors: Robin, M.; Porcher, R.; Zinke, W.; Van Biezen, A.N.J.A.; Volin, L.; Mufti, G.; Craddock, C.; Finke, J.; Richard, C.; Passweg, J.; Peniket, A.; Martens, J.; Sucak, G.; Gedde-Dahk, T.; Vitek, A.; Nagler, A.; Blaise, D.; Beelen, D.; Maillard, N.; Schwerdtfeger, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A PHASE II STUDY OF LENALIDOMIDE AND RITUXIMAB (R²) COMBINATION IN PATIENTS WITH HIGH‐RISK REFRACTORY/RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) Authors: Bouabdallah, R.; Zemmour, C.; Schiano de Collela, J.; Slama, B.; Bladé, J.; Belmecheri, N.; Coso, D.; Montes de Oca, C.; Stoppa, A.; Aurran‐Schleinitz, T.; Cournier, S.; Ivanov, V.; Mescam, L.; Blaise, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Allelopathic intercrops and its mulch as an integrated weed management strategy for rainfed Bt-transgenic cotton hybrids. (September 2020) Authors: Blaise, D.; Manikandan, A.; Verma, P.; Nalayini, P.; Chakraborty, M.; Kranthi, K.R. Journal: Crop protection Issue: Volume 135(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ALLO HSCT IN OLDER PATIENTS: A QUESTION OF REAL PERSONALIZED MEDICINE. (May 2023) Authors: Blaise, D. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY. (June 2017) Authors: Bazarbachi, A.; Boumendil, A.; Finel, H.; Mohty, M.; Castagna, L.; Blaise, D.; Peggs, K.; Afanasyev, B.; Diez‐Martin, J.; Corradini, P.; Socié, G.; Robinson, S.; Gutiérrez‐García, G.; Bonifazi, F.; Yakoub‐Agha, I.; Gülbas, Z.; Bloor, A.; Delage, J.; Esquirol, A.; Malladi, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES. (12th June 2019) Authors: de Philippis, C.; Legrande, F.; Bramanti, S.; Montes de Oca, C.; Dulery, R.; Bouabdallah, R.; Granada, A.; Devillier, R.; Mariotti, J.; Sarina, B.; Harbi, S.; Maisano, V.; Furst, S.; Pagliardini, T.; Weiller, P.J.; Lemarie, C.; Calmels, B.; Chabannon, C.; Carlo‐Stella, C.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia. (5th January 2018) Authors: Craddock, C.; Versluis, J.; Labopin, M.; Socie, G.; Huynh, A.; Deconinck, E.; Volin, L.; Milpied, N.; Bourhis, J. H.; Rambaldi, A.; Chevallier, P.; Blaise, D.; Manz, M.; Vellenga, E.; Vekemans, M‐C.; Maertens, J.; Passweg, J.; Vyas, P.; Schmid, C.; Löwenberg, B. Journal: Journal of internal medicine Issue: Volume 283:Number 4(2018) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP. (12th June 2019) Authors: Bazarbachi, A.; Boumendil, A.; Finel, H.; Castagna, L.; Dominietto, A.; Blaise, D.; Diez‐Martin, J.; Tischer, J.; Gülbas, Z.; Labussière Wallet, H.; Lopez Corral, L.; Mohty, M.; Koc, Y.; Yakoub‐Agha, I.; Schmid, C.; el Cheikh, J.; Arat, M.; Forcade, E.; Dreger, P.; Rocha, V. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗